• Category: Business
Leadership watch: Haag-Stret, Heidelberg, and Samsara name new executives
Business

Leadership watch: Haag-Stret, Heidelberg, and Samsara name new executives

Check out the latest leadership news from the eyecare space, including a new CEO at Haag-Streit and other major appointments.
Neurolens debuts official rebrand as Newton
Business

Neurolens debuts official rebrand as Newton

Maker of the first and only therapeutic lenses clinically proven to relieve eye misalignment symptoms announces next chapter in its eyecare journey.
Topcon invests in Senseye's ocular biomarker-based mental health platform
Business

Topcon invests in Senseye's ocular biomarker-based mental health platform

First app of its kind utilizes the eye as a non-invasive window to the brain to identify neuropsychiatric conditions—in just 15 minutes.
OpZira launches with LumiThera diagnostic product line
Business

OpZira launches with LumiThera diagnostic product line

Spin-off company official forms following Alcon-LumiThera acquisition to offer two ophthalmic products: the AdaptDx Pro and NOVA Vision Testing System.
Alcon officially purchases LumiThera
Business

Alcon officially purchases LumiThera

Acquisition of the Valeda Light Delivery System includes plans to expand commercial market availability in 2026.
Barti raises $12M to support expansion of AI-based eyecare EHR
Business

Barti raises $12M to support expansion of AI-based eyecare EHR

Financing to further advance software company’s advancement toward integration in ophthalmology and development of new automated, AI-embedded offerings.
Leadership watch: J&J and Rebion appoint new executives
Business

Leadership watch: J&J and Rebion appoint new executives

Opthea to lay off 80% of workforce amid executive cuts
Business

Opthea to lay off 80% of workforce amid executive cuts

Company also announces cuts to Board of Directors as the CEO is among several planned departures beginning in September. 
Updated reciprocal tariffs to take effect this week
Business

Updated reciprocal tariffs to take effect this week

With new rates hitting Aug. 7, take a look at how the optical industry will be impacted as top trade partners face an increase on U.S. imports.
Alcon to acquire STAAR Surgical
Business

Alcon to acquire STAAR Surgical

The $1.5 billion deal includes STAAR’s FDA-approved implantable collamer lenses; expected to close within 6 to 12 months.
Topcon acquires Intelligent Retinal Imaging Systems
Business

Topcon acquires Intelligent Retinal Imaging Systems

As part of the
Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes
Business

Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes

Check out the latest leadership news from the eyecare space, including two new execs at PolyActiva and a retinal disorder treatment specialist taking the helm at Wills Eye.
Topcon invests in OKKO Health's home vision monitoring platform
Business

Topcon invests in OKKO Health's home vision monitoring platform

The OKKO Health app is available on patients’ digital devices to enable ongoing self-monitoring of macular degeneration.
Clearside exploring options to advance suprachoroidal delivery platform
Business

Clearside exploring options to advance suprachoroidal delivery platform

Company pauses all other research programs, transitions employees to consulting roles, and shares phase 3 plans for wet AMD candidate while focusing on the SCS Microinjector.
Harrow purchases US commercialization rights to Samsung Bioepis' biosimilar portfolio
Business

Harrow purchases US commercialization rights to Samsung Bioepis' biosimilar portfolio

Acquisition includes two major anti-VEGF therapies for retinal diseases: OPUVIZ and BYOOVIZ, generic equivalents to EYLEA and Lucentis, respectively.
Meta reportedly buys minority stake in EssilorLuxottica
Business

Meta reportedly buys minority stake in EssilorLuxottica

The estimated $3.51 billion investment follows companies’ recent plans to launch AI-powered smart glasses for the Oakley sports performance frames this summer.
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Business

Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions

Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.
 4DMT cuts 25% of workforce and fast-tracks wet AMD gene therapy program
Business

4DMT cuts 25% of workforce and fast-tracks wet AMD gene therapy program

Company reports streamlined planning to advance phase 3 clinical trials of 4D-150, under evaluation to deliver a single, low-dose, and sustained multi-year intravitreal injection.
Alcon to purchase LumiThera
Business

Alcon to purchase LumiThera

Targeting a Q3 sale, acquisition includes Valeda Light Delivery System, the first and only PBM treatment for early-to-intermediate dry AMD.
Eyenovia rebrands as Hyperion DeFi, Inc with new focus
Business

Eyenovia rebrands as Hyperion DeFi, Inc with new focus

Name change aligns with company's pivot toward decentralized finance and focus on a cryptocurrency treasury reserve strategy; plans remain to commercialize Optejet.